Methylprednisolone Sodium Succinate Injection, Powder, Lyophilized, For Solution
Product Images NDC 55150-264

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Methylprednisolone Sodium Succinate (NDC 55150-264). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Methylprednisolone Sodium Succinate Chemical Structure (Methylprednisolone Str)

Chemical structure diagram of Methylprednisolone Sodium Succinate, showing the steroid backbone with hydroxyl, methyl, carbonyl groups, and the sodium succinate moiety attached.*

FDA Label Image

Package Label-principal Display Panel (40 mg per vial)

Label for Methylprednisolone Sodium Succinate for Injection, USP 40 mg per vial, lyophilized powder for injection. Single dose vial intended for intramuscular or intravenous use. Manufactured for AuroMedics Pharma LLC, Dayton, NJ. Includes barcode, NDC 55150-262-03, and usage instructions to discard unused portion and protect from light.*

FDA Label Image

Package Label-principal Display Panel (40 mg per vial)

Packaging label for Methylprednisolone Sodium Succinate injection, USP, 40 mg per vial. The product is a lyophilized powder for intramuscular or intravenous use, supplied as 25 single dose vials by Auromedics Pharma LLC and manufactured by Aurobindo Pharma Limited in India. The label includes storage instructions, a note that the package does not contain diluent, and a barcode.*

FDA Label Image

Ckage Label-principal Display Panel (125 mg per vial)

Methylprednisolone Sodium Succinate for Injection, USP 125 mg per vial label. This lyophilized powder injection is for intramuscular or intravenous use only. The single-dose vial is labeled with dosage instructions, manufacturer information (AuroMedics Pharma LLC, Dayton, NJ), and handling precautions including protection from light and discarding unused portions.*

FDA Label Image

Methylprednisolone-figure 4 (Methylprednisolone Fig4)

Packaging label for Methylprednisolone Sodium Succinate injection, USP, 125 mg per vial. Dosage form is lyophilized powder for solution, for intramuscular or intravenous use only. The box contains 25 single dose vials. Manufactured by Aurobindo Pharma Limited and labeled for AuroMedics Pharma LLC. Storage instructions and a caution that the package does not contain diluent are also visible.*

FDA Label Image

Package Label-principal Display Panel (500 mg per vial)

Label for Methylprednisolone Sodium Succinate Injection, USP 500 mg per vial, lyophilized powder for intramuscular or intravenous use. The label includes storage instructions, reconstitution directions, and manufacturer information for AuroMedics Pharma LLC, Dayton, NJ. The vial is multiple dose with specified concentration after reconstitution.*

FDA Label Image

Package Label-principal Display Panel (500 mg per vial)

Packaging label for Methylprednisolone Sodium Succinate for Injection, USP, 500 mg per vial. The product is a lyophilized powder injection for intramuscular or intravenous use. The label notes the absence of diluent in the package, with benzyl alcohol recommended as a preservative. Manufactured by AuroMedics Pharma LLC and Aurobindo Pharma Limited, the label includes storage instructions, dosage form, and warnings.*

FDA Label Image

Package Label-principal Display Panel (2 grams per vial)

Label for Methylprednisolone Sodium Succinate injection, USP, 2 grams per vial, lyophilized powder for solution. Intended for intramuscular or intravenous use only. Manufactured by AuroMedics Pharma LLC, Dayton, NJ. Includes storage instructions and cautions about reconstitution and use.*

FDA Label Image

Package Label-principal Display Panel (2 grams per vial)

Packaging label for Methylprednisolone Sodium Succinate Injection, USP 2 grams per vial, lyophilized powder for intramuscular or intravenous use. The label indicates the product is single dose, sterile, and non-pyrogenic, manufactured by Aurobindo Pharma Limited for AuroMedics Pharma LLC. The package does not contain diluent; recommended diluent contains benzyl alcohol as a preservative.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.